The HinduLean L·
Natco Pharma gets USFDA nod for generic cancer drug, shares rise 4% intra-day
Natco Pharma said it will manufacture Olaparib tablets, while its partner Alembic Pharmaceuticals wil distribute the product in the U.S.
Read at The Hindu →

